VIVS
VivoSim Labs, INC.
Company overview
- Market capitalization
- $3.27M
- Employees
- 14
- Latest publication
- 2026-09-29
About VivoSim Labs, INC.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-06-30 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD | Q1 20252024-06-30 · USD | Q4 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 18,000USD | 26,000USD | 28,000USD | 51,000USD | 24,000USD | 30,000USD | 39,000USD | 29,000USD |
| Cost Of Revenue | 0USD | 0USD | 0USD | 0USD | 2,000USD | 1,000USD | 2,000USD | — |
| Gross Profit | 18,000USD | 26,000USD | 28,000USD | 51,000USD | 22,000USD | 29,000USD | 37,000USD | 29,000USD |
| Research Development | 1,132,000USD | 1,140,000USD | 923,000USD | 859,000USD | 1,780,000USD | 984,000USD | 1,402,000USD | 1,063,000USD |
| Selling General Administrative | 1,645,000USD | 1,633,000USD | 1,736,000USD | 2,342,000USD | 1,699,000USD | 1,641,000USD | 2,009,000USD | 2,050,000USD |
| Total Operating Expenses | 2,777,000USD | 2,776,000USD | 2,663,000USD | 3,205,000USD | 3,490,000USD | 2,637,000USD | 3,423,000USD | 3,125,000USD |
| Operating Income | -2,759,000USD | -2,750,000USD | -2,635,000USD | -3,154,000USD | -3,468,000USD | -2,608,000USD | -3,386,000USD | -3,096,000USD |
| Total Other Income Expense Net | 1,424,000USD | 59,000USD | 92,000USD | 10,006,000USD | 21,000USD | 59,000USD | 44,000USD | 51,000USD |
| Interest Income | 28,000USD | 63,000USD | 92,000USD | 11,000USD | 26,000USD | 59,000USD | 44,000USD | 51,000USD |
| Interest Expense | 4,000USD | 4,000USD | 0USD | 5,000USD | 5,000USD | 0USD | 0USD | — |
| Income Before Tax | -1,335,000USD | -2,691,000USD | -2,543,000USD | 6,852,000USD | -3,447,000USD | -2,549,000USD | -3,342,000USD | -3,045,000USD |
| Income Tax Expense | 3,000USD | — | 2,000USD | — | — | — | 2,000USD | — |
| Net Income | -1,338,000USD | -2,691,000USD | -2,545,000USD | 6,852,000USD | -3,447,000USD | -2,549,000USD | -3,344,000USD | -3,045,000USD |
| Net Interest Income | — | 59,000USD | 92,000USD | 6,000USD | 21,000USD | 59,000USD | 44,000USD | 51,000USD |
| Tax Provision | — | 0USD | 2,000USD | 0USD | 0USD | 0USD | 2,000USD | 0USD |
| Net Income From Continuing Ops | — | -2,691,000USD | -2,545,000USD | 6,852,000USD | -3,447,000USD | -2,549,000USD | -3,344,000USD | -3,045,000USD |
| Ebit | — | -2,687,000USD | -2,543,000USD | 6,857,000USD | -3,442,000USD | -2,549,000USD | -3,342,000USD | -3,045,000USD |
| Ebitda | — | -2,635,000USD | -2,484,000USD | 6,918,000USD | -3,375,000USD | -2,481,000USD | -3,272,000USD | -2,974,000USD |
| Depreciation And Amortization | — | 52,000USD | 59,000USD | 61,000USD | 67,000USD | 68,000USD | 70,000USD | 71,000USD |
| Reconciled Depreciation | — | 52,000USD | 59,000USD | 61,000USD | 67,000USD | 68,000USD | 70,000USD | 71,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 131,000USD | 144,000USD | 109,000USD | 370,000USD | 1,500,000USD | 0USD | 2,196,000USD | 3,091,000USD |
| Cost Of Revenue | 0USD | 5,000USD | 0USD | — | — | 0USD | 328,000USD | 482,000USD |
| Gross Profit | 131,000USD | 139,000USD | 109,000USD | 370,000USD | 1,500,000USD | 0USD | 1,868,000USD | 2,609,000USD |
| Research Development | 4,189,000USD | 5,025,000USD | 5,498,000USD | 8,885,000USD | 3,320,000USD | 1,103,000USD | 5,284,000USD | 14,752,000USD |
| Selling General Administrative | 7,429,000USD | 7,691,000USD | 9,644,000USD | 9,088,000USD | 9,631,000USD | 15,708,000USD | 17,150,000USD | 14,702,000USD |
| Total Operating Expenses | 11,618,000USD | 12,755,000USD | 15,195,000USD | 18,101,000USD | 12,979,000USD | 16,826,000USD | 23,343,000USD | 29,883,000USD |
| Operating Income | -11,487,000USD | -12,616,000USD | -15,086,000USD | -17,731,000USD | -11,479,000USD | -16,826,000USD | -21,475,000USD | -27,274,000USD |
| Total Other Income Expense Net | -2,354,000USD | 10,130,000USD | 417,000USD | 474,000USD | 33,000USD | 2,000USD | 2,767,000USD | 642,000USD |
| Interest Income | 267,000USD | 140,000USD | 405,000USD | 454,000USD | 8,000USD | 15,000USD | — | — |
| Interest Expense | 12,000USD | 10,000USD | 0USD | — | — | — | — | — |
| Income Before Tax | -13,841,000USD | -2,486,000USD | -14,669,000USD | -17,257,000USD | -11,446,000USD | -16,824,000USD | -18,708,000USD | -26,632,000USD |
| Income Tax Expense | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 3,000USD |
| Net Income | -13,843,000USD | -2,488,000USD | -14,671,000USD | -17,259,000USD | -11,448,000USD | -16,826,000USD | -18,710,000USD | -26,635,000USD |
| Net Interest Income | — | 130,000USD | 405,000USD | 454,000USD | 8,000USD | 15,000USD | — | — |
| Tax Provision | — | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | — | — |
| Net Income From Continuing Ops | — | -2,488,000USD | -14,671,000USD | -17,259,000USD | -11,448,000USD | -16,826,000USD | — | — |
| Ebit | — | -2,476,000USD | -14,669,000USD | -17,257,000USD | -11,446,000USD | -14,018,000USD | -21,475,000USD | -27,274,000USD |
| Ebitda | — | -2,210,000USD | -14,389,000USD | -16,964,000USD | -11,304,000USD | -13,977,000USD | -20,333,000USD | -26,294,000USD |
| Depreciation And Amortization | — | 266,000USD | 280,000USD | 293,000USD | 142,000USD | 41,000USD | 1,142,000USD | 980,000USD |
| Reconciled Depreciation | — | 266,000USD | 280,000USD | 293,000USD | 142,000USD | 41,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD | Q1 20252024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,847,000USD | 7,386,000USD | 6,960,000USD | 9,686,000USD | 14,650,000USD | 3,844,000USD | 6,754,000USD | 9,470,000USD |
| Cash And Equivalents | 1,670,000USD | 5,024,000USD | — | — | — | — | — | — |
| Total Current Assets | 3,226,000USD | 6,627,000USD | 6,041,000USD | 7,591,000USD | 12,131,000USD | 2,100,000USD | 4,783,000USD | 7,283,000USD |
| Other Current Assets | 511,000USD | 557,000USD | 709,000USD | 882,000USD | 789,000USD | 913,000USD | 940,000USD | 640,000USD |
| Total Liabilities | 6,193,000USD | 8,485,000USD | — | — | — | — | — | — |
| Total Current Liabilities | 1,893,000USD | 2,785,000USD | 2,475,000USD | 2,449,000USD | 3,737,000USD | 2,937,000USD | 2,414,000USD | 2,033,000USD |
| Other Current Liabilities | 9,000USD | 981,000USD | — | — | — | — | — | — |
| Total Stockholder Equity | -2,346,000USD | -1,099,000USD | 4,441,000USD | 7,065,000USD | 10,492,000USD | 364,000USD | 3,680,000USD | 6,662,000USD |
| Total Equity Including Noncontrolling Interest | -2,346,000USD | -1,099,000USD | — | — | — | — | — | — |
| Net Receivables | 29,000USD | 32,000USD | 1,044,000USD | 32,000USD | 30,000USD | 26,000USD | 29,000USD | 48,000USD |
| Property Plant Equipment Net | 476,000USD | 613,000USD | 773,000USD | 941,000USD | 1,286,000USD | 1,457,000USD | 1,631,000USD | 1,795,000USD |
| Accounts Payable | 621,000USD | 1,021,000USD | 671,000USD | 580,000USD | 1,644,000USD | 930,000USD | 419,000USD | 1,119,000USD |
| Short Term Debt | 316,000USD | 447,000USD | 533,000USD | 528,000USD | 521,000USD | 517,000USD | 513,000USD | 510,000USD |
| Common Stock | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 2,000USD | 17,000USD | 15,000USD | 14,000USD |
| Retained Earnings | -357,338,000USD | -356,000,000USD | -350,236,000USD | -347,545,000USD | -342,157,000USD | -349,009,000USD | -345,562,000USD | -343,013,000USD |
| Total Liab | — | — | 2,519,000USD | 2,621,000USD | 4,158,000USD | 3,480,000USD | 3,074,000USD | 2,808,000USD |
| Other Current Liab | — | — | 1,271,000USD | 1,341,000USD | 1,572,000USD | 1,490,000USD | 1,482,000USD | 404,000USD |
| Capital Stock | — | — | 3,000USD | 3,000USD | 2,000USD | 17,000USD | 15,000USD | 14,000USD |
| Cash | — | — | 4,288,000USD | 6,677,000USD | 11,312,000USD | 1,161,000USD | 3,174,000USD | 6,187,000USD |
| Cash And Short Term Investments | — | — | 4,288,000USD | 6,677,000USD | 11,312,000USD | 1,161,000USD | 3,174,000USD | 6,187,000USD |
| Net Debt | — | — | -3,711,000USD | -5,977,000USD | -10,370,000USD | -101,000USD | -2,001,000USD | -4,902,000USD |
| Short Long Term Debt Total | — | — | 577,000USD | 700,000USD | 942,000USD | 1,060,000USD | 1,173,000USD | 1,285,000USD |
| Property Plant Equipment Gross | — | — | 773,000USD | 941,000USD | 2,807,000USD | 1,457,000USD | 1,631,000USD | 1,795,000USD |
| Common Stock Shares Outstanding | — | — | 1,463,609shares | 1,463,609shares | 1,463,609shares | 1,504,713shares | 1,499,544shares | 1,221,974shares |
| Non Current Assets Total | — | — | 919,000USD | 2,095,000USD | 2,519,000USD | 1,744,000USD | 1,971,000USD | 2,187,000USD |
| Non Current Liabilities Total | — | — | 44,000USD | 172,000USD | 421,000USD | 543,000USD | 660,000USD | 775,000USD |
| Non Currrent Assets Other | — | — | 146,000USD | 1,154,000USD | 1,233,000USD | 287,000USD | 340,000USD | 392,000USD |
| Net Working Capital | — | — | 3,566,000USD | 5,142,000USD | 8,394,000USD | -837,000USD | 2,369,000USD | 5,250,000USD |
| Unclassified Equity | — | — | 354,671,000USD | 354,604,000USD | 352,645,000USD | 349,339,000USD | 349,211,000USD | 349,647,000USD |
| Inventory | — | — | — | — | 0USD | 0USD | 640,000USD | 408,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | 1,000USD | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 7,386,000USD | 14,650,000USD | 6,349,000USD | 20,313,000USD | 33,296,000USD | 39,917,000USD | 28,441,000USD | 40,623,000USD |
| Cash And Equivalents | 5,024,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 6,627,000USD | 12,131,000USD | 3,936,000USD | 17,048,000USD | 29,533,000USD | 38,398,000USD | 28,318,000USD | 38,574,000USD |
| Other Current Assets | 557,000USD | 789,000USD | 705,000USD | 889,000USD | 858,000USD | 1,034,000USD | 851,000USD | 1,049,000USD |
| Total Liabilities | 8,485,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,785,000USD | 3,737,000USD | 1,860,000USD | 3,671,000USD | 1,383,000USD | 721,000USD | 1,810,000USD | 3,737,000USD |
| Other Current Liabilities | 981,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -1,099,000USD | 10,492,000USD | 3,601,000USD | 15,329,000USD | 30,209,000USD | 39,196,000USD | 26,631,000USD | 36,298,000USD |
| Total Equity Including Noncontrolling Interest | -1,099,000USD | — | — | — | — | — | — | — |
| Net Receivables | 32,000USD | 30,000USD | 33,000USD | 152,000USD | 0USD | 0USD | 111,000USD | 558,000USD |
| Property Plant Equipment Net | 613,000USD | 1,286,000USD | 1,968,000USD | 2,607,000USD | 2,815,000USD | 381,000USD | — | 1,832,000USD |
| Accounts Payable | 1,021,000USD | 1,644,000USD | 627,000USD | 331,000USD | 415,000USD | 281,000USD | 720,000USD | 628,000USD |
| Short Term Debt | 447,000USD | 521,000USD | 506,000USD | 492,000USD | 479,000USD | — | — | — |
| Common Stock | 3,000USD | 2,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD | 7,000USD | 124,000USD |
| Retained Earnings | -356,000,000USD | -342,157,000USD | -339,669,000USD | -324,998,000USD | -307,739,000USD | -296,291,000USD | -279,465,000USD | -260,755,000USD |
| Total Liab | — | 4,158,000USD | 2,748,000USD | 4,984,000USD | 3,087,000USD | 721,000USD | 1,810,000USD | 4,325,000USD |
| Other Current Liab | — | 1,572,000USD | 727,000USD | 2,848,000USD | 489,000USD | 440,000USD | 1,090,000USD | 2,584,000USD |
| Capital Stock | — | 2,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD | — | — |
| Cash | — | 11,312,000USD | 2,901,000USD | 15,301,000USD | 28,675,000USD | 37,364,000USD | 27,356,000USD | 36,477,000USD |
| Cash And Short Term Investments | — | 11,312,000USD | 2,901,000USD | 16,007,000USD | 28,675,000USD | 37,364,000USD | 27,356,000USD | 36,477,000USD |
| Net Debt | — | -10,370,000USD | -1,507,000USD | -13,496,000USD | -26,492,000USD | -37,364,000USD | -27,356,000USD | -36,477,000USD |
| Short Long Term Debt Total | — | 942,000USD | 1,394,000USD | 1,805,000USD | 2,183,000USD | — | — | — |
| Inventory | — | 0USD | 297,000USD | 0USD | — | — | — | 490,000USD |
| Property Plant Equipment Gross | — | 2,807,000USD | 3,226,000USD | 3,883,000USD | 3,886,000USD | 1,383,000USD | — | — |
| Common Stock Shares Outstanding | — | 1,463,609shares | 762,076shares | 726,085shares | 725,299shares | 575,166shares | 539,817shares | 480,749shares |
| Non Current Assets Total | — | 2,519,000USD | 2,413,000USD | 3,265,000USD | 3,763,000USD | 1,519,000USD | 123,000USD | 2,049,000USD |
| Non Current Liabilities Total | — | 421,000USD | 888,000USD | 1,313,000USD | 1,704,000USD | 0USD | — | 588,000USD |
| Non Currrent Assets Other | — | 1,233,000USD | 445,000USD | 658,000USD | 948,000USD | 1,138,000USD | 123,000USD | 217,000USD |
| Net Working Capital | — | 8,394,000USD | 2,076,000USD | 13,377,000USD | 28,150,000USD | 37,677,000USD | — | — |
| Unclassified Equity | — | 352,645,000USD | 343,250,000USD | 340,307,000USD | 337,930,000USD | 335,469,000USD | 306,089,000USD | 296,929,000USD |
| Short Term Investments | — | — | 0USD | 706,000USD | 0USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | 2,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | — | — | 1,313,000USD | 1,704,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 525,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-06-30 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD | Q1 20252024-06-30 · USD | Q4 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 40,000USD | 52,000USD | 59,000USD | 61,000USD | 67,000USD | 68,000USD | 70,000USD | 71,000USD |
| Change To Account Receivables | 3,000USD | -1,000USD | 0USD | -4,000USD | 3,000USD | 19,000USD | -15,000USD | 0USD |
| Change To Liabilities | -643,000USD | — | — | — | — | — | — | — |
| Change In Working Capital | -350,000USD | 188,000USD | 19,000USD | 530,000USD | 815,000USD | -465,000USD | 157,000USD | 116,000USD |
| Operating Cash Flow | -3,213,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -23,000USD | 0USD | 0USD | 0USD | 0USD | -13,000USD | 0USD | 0USD |
| Investing Cash Flow | -23,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | -118,000USD | — | — | — | — | — | — | — |
| Change In Cash | -3,354,000USD | -2,389,000USD | -2,378,000USD | 10,151,000USD | -2,013,000USD | -3,013,000USD | 3,286,000USD | -2,394,000USD |
| End Cash Flow | 1,813,000USD | — | — | — | — | — | — | — |
| Net Income | — | -2,691,000USD | -2,545,000USD | 6,852,000USD | -3,447,000USD | -2,549,000USD | -3,344,000USD | -3,045,000USD |
| Stock Based Compensation | — | 67,000USD | 72,000USD | 91,000USD | 130,000USD | 155,000USD | 156,000USD | 201,000USD |
| Other Non Cash Items | — | 113,000USD | 89,000USD | -9,569,000USD | 634,000USD | 149,000USD | -22,000USD | -14,000USD |
| Change To Inventory | — | 0USD | 0USD | 0USD | 2,000USD | -392,000USD | -111,000USD | — |
| Total Cash From Operating Activities | — | -2,271,000USD | -2,378,000USD | -2,035,000USD | -1,801,000USD | -2,642,000USD | -2,983,000USD | -2,671,000USD |
| Free Cash Flow | — | -2,271,000USD | -2,378,000USD | -2,035,000USD | -1,801,000USD | -2,655,000USD | -2,983,000USD | -2,671,000USD |
| Investments | — | 0USD | 0USD | 9,001,000USD | 4,000USD | 13,000USD | 20,000USD | 13,000USD |
| Total Cash From Financing Activities | — | -118,000USD | 0USD | 3,185,000USD | -216,000USD | -371,000USD | 6,249,000USD | 264,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 3,185,000USD | -216,000USD | -371,000USD | 6,249,000USD | 264,000USD |
| Begin Period Cash Flow | — | 6,820,000USD | 9,198,000USD | 1,304,000USD | 3,317,000USD | 6,330,000USD | 3,044,000USD | 5,438,000USD |
| End Period Cash Flow | — | 4,431,000USD | 6,820,000USD | 11,455,000USD | 1,304,000USD | 3,317,000USD | 6,330,000USD | 3,044,000USD |
| Other Cashflows From Financing Activities | — | -118,000USD | — | — | — | — | — | — |
| Total Cashflows From Investing Activities | — | — | — | 9,001,000USD | 4,000USD | — | 20,000USD | 13,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13,843,000USD | -2,488,000USD | -14,671,000USD | -17,259,000USD | -11,448,000USD | -16,826,000USD | -18,710,000USD | -26,635,000USD |
| Depreciation | 215,000USD | 266,000USD | 280,000USD | 293,000USD | 142,000USD | 41,000USD | 1,142,000USD | 980,000USD |
| Other Non Cash Items | 0USD | -8,808,000USD | -154,000USD | -125,000USD | 2,256,000USD | 19,000USD | -424,000USD | 63,000USD |
| Unclassified Operating Cash Flow | 2,756,000USD | — | — | — | -2,256,000USD | — | — | — |
| Change To Account Receivables | -2,000USD | 3,000USD | 119,000USD | -152,000USD | 0USD | 111,000USD | 447,000USD | 470,000USD |
| Change To Inventory | 0USD | -501,000USD | -297,000USD | 0USD | — | 0USD | 276,000USD | 352,000USD |
| Change To Liabilities | -868,000USD | — | — | — | — | — | — | — |
| Change In Working Capital | 45,000USD | 1,037,000USD | -1,616,000USD | 2,306,000USD | 597,000USD | -2,113,000USD | -998,000USD | 24,000USD |
| Operating Cash Flow | -10,827,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | 0USD | -13,000USD | -42,000USD | -396,000USD | -409,000USD | -405,000USD | 0USD | -79,000USD |
| Unclassified Investing Cash Flow | 94,000USD | -8,987,000USD | — | — | — | — | — | — |
| Investing Cash Flow | 94,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 4,445,000USD | — | — | — | — | — | — | — |
| Change In Cash | -6,288,000USD | 8,411,000USD | -12,400,000USD | -13,374,000USD | -8,657,000USD | 10,119,000USD | -9,200,000USD | -7,297,000USD |
| End Cash Flow | 5,167,000USD | — | — | — | — | — | — | — |
| Stock Based Compensation | — | 532,000USD | 1,508,000USD | 2,377,000USD | 2,256,000USD | 5,556,000USD | 4,108,000USD | 5,193,000USD |
| Total Cash From Operating Activities | — | -9,461,000USD | -14,653,000USD | -12,408,000USD | -8,453,000USD | -13,323,000USD | -14,882,000USD | -20,375,000USD |
| Free Cash Flow | — | -9,474,000USD | -14,695,000USD | -12,804,000USD | -8,862,000USD | -13,728,000USD | -14,882,000USD | -20,454,000USD |
| Investments | — | 9,025,000USD | 816,000USD | -966,000USD | -409,000USD | -393,000USD | — | — |
| Total Cashflows From Investing Activities | — | 9,025,000USD | 816,000USD | -966,000USD | -409,000USD | -393,000USD | 747,000USD | -76,000USD |
| Total Cash From Financing Activities | — | 8,847,000USD | 1,437,000USD | 0USD | 205,000USD | 23,835,000USD | 4,935,000USD | 13,154,000USD |
| Issuance Of Capital Stock | — | 8,847,000USD | 1,437,000USD | 0USD | 251,000USD | 23,798,000USD | — | — |
| Begin Period Cash Flow | — | 3,044,000USD | 15,444,000USD | 28,818,000USD | 37,475,000USD | 27,356,000USD | 36,556,000USD | 43,853,000USD |
| End Period Cash Flow | — | 11,455,000USD | 3,044,000USD | 15,444,000USD | 28,818,000USD | 37,475,000USD | 27,356,000USD | 36,556,000USD |
| Other Cashflows From Investing Activities | — | 9,000,000USD | — | — | — | 12,000USD | 747,000USD | 3,000USD |
| Sale Purchase Of Stock | — | — | — | — | 0USD | -1,000USD | — | — |
| Other Cashflows From Financing Activities | — | — | — | — | -46,000USD | 38,000USD | -61,000USD | -173,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 23,798,000USD | 4,996,000USD | 13,327,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2025Quarterly · 2024-12-31 | Product | Product | 9,000 | USD | 0001193125-26-046520 |
| Q3 2025Quarterly · 2024-12-31 | Product | Royalty | 15,000 | USD | 0001193125-26-046520 |
| Q2 2025Quarterly · 2024-09-30 | Product | Product | 2,000 | USD | 0001193125-25-269483 |
| Q2 2025Quarterly · 2024-09-30 | Product | Royalty | 28,000 | USD | 0001193125-25-269483 |
| Q1 2025Quarterly · 2024-06-30 | Product | Product | 14,000 | USD | 0000950170-24-090726 |
| Q1 2025Quarterly · 2024-06-30 | Product | Royalty | 25,000 | USD | 0000950170-24-090726 |
| Q3 2024Quarterly · 2023-12-31 | Product | Product | 0 | USD | 0000950170-25-022778 |
| Q3 2024Quarterly · 2023-12-31 | Product | Royalty | 5,000 | USD | 0000950170-25-022778 |
| Q1 2024Quarterly · 2023-06-30 | Product | Product | 0 | USD | 0000950170-24-090726 |
| Q1 2024Quarterly · 2023-06-30 | Product | Royalty | 75,000 | USD | 0000950170-24-090726 |
| Q4 2020Quarterly · 2020-03-31 | Product | Grant | 0 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-03-31 | Product | License And Service | 0 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-03-31 | Product | Products And Services | 0 | USD | Legacy provider |
| FY 2020Yearly · 2020-03-31 | Product | Grant | 52,000 | USD | 0001564590-21-032980 |
| FY 2020Yearly · 2020-03-31 | Product | License And Service | 89,000 | USD | 0001564590-21-032980 |
| FY 2020Yearly · 2020-03-31 | Product | Products And Services | 2,055,000 | USD | 0001564590-21-032980 |
| Q3 2020Quarterly · 2019-12-31 | Product | Grant | 0 | USD | 0001564590-21-004687 |
| Q3 2020Quarterly · 2019-12-31 | Product | License And Service | 70,000 | USD | 0001564590-21-004687 |
| Q3 2020Quarterly · 2019-12-31 | Product | Products And Services | 228,000 | USD | 0001564590-21-004687 |
| Q2 2020Quarterly · 2019-09-30 | Product | Grant | 0 | USD | 0001564590-20-051311 |
| Q2 2020Quarterly · 2019-09-30 | Product | License And Service | 9,000 | USD | 0001564590-20-051311 |
| Q2 2020Quarterly · 2019-09-30 | Product | Products And Services | 1,221,000 | USD | 0001564590-20-051311 |
| FY 2019Yearly · 2019-03-31 | Product | Grant | 587,000 | USD | 0001564590-20-027310 |
| FY 2019Yearly · 2019-03-31 | Product | License And Service | 171,000 | USD | 0001564590-20-027310 |
| FY 2019Yearly · 2019-03-31 | Product | Products And Services | 2,333,000 | USD | 0001564590-20-027310 |
| FY 2018Yearly · 2018-03-31 | Product | Grant | 554,000 | USD | 0001564590-19-021444 |
| FY 2018Yearly · 2018-03-31 | Product | License And Service | 422,000 | USD | 0001564590-19-021444 |
| FY 2018Yearly · 2018-03-31 | Product | Products And Services | 3,627,000 | USD | 0001564590-19-021444 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.